181 related articles for article (PubMed ID: 18588888)
21. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
22. Conformation and energy investigation of microtubule longitudinal dynamic instability induced by natural products.
Chu Y; Tian Z; Yang M; Li W
Chem Biol Drug Des; 2023 Sep; 102(3):444-456. PubMed ID: 36509697
[TBL] [Abstract][Full Text] [Related]
23. Double-sides sticking mechanism of vinblastine interacting with α,β-tubulin to get activity against cancer cells.
Zhou X; Xu Z; Li A; Zhang Z; Xu S
J Biomol Struct Dyn; 2019 Sep; 37(15):4080-4091. PubMed ID: 30451089
[TBL] [Abstract][Full Text] [Related]
24. The catastrophe-promoting activity of ectopic Op18/stathmin is required for disruption of mitotic spindles but not interphase microtubules.
Holmfeldt P; Larsson N; Segerman B; Howell B; Morabito J; Cassimeris L; Gullberg M
Mol Biol Cell; 2001 Jan; 12(1):73-83. PubMed ID: 11160824
[TBL] [Abstract][Full Text] [Related]
25. Model for stathmin/OP18 binding to tubulin.
Wallon G; Rappsilber J; Mann M; Serrano L
EMBO J; 2000 Jan; 19(2):213-22. PubMed ID: 10637225
[TBL] [Abstract][Full Text] [Related]
26. The oncoprotein 18/stathmin family of microtubule destabilizers.
Cassimeris L
Curr Opin Cell Biol; 2002 Feb; 14(1):18-24. PubMed ID: 11792540
[TBL] [Abstract][Full Text] [Related]
27. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
Wilson L; Panda D; Jordan MA
Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for the regulation of tubulin by vinblastine.
Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
[TBL] [Abstract][Full Text] [Related]
29. Op18/Stathmin counteracts the activity of overexpressed tubulin-disrupting proteins in a human leukemia cell line.
Sellin ME; Holmfeldt P; Stenmark S; Gullberg M
Exp Cell Res; 2008 Apr; 314(6):1367-77. PubMed ID: 18262179
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Microtubule-Associated Proteins (MAPs) and Tubulin Interactions by Isothermal Titration Calorimetry (ITC).
Tsvetkov PO; La Rocca R; Malesinski S; Devred F
Methods Mol Biol; 2019; 1964():151-165. PubMed ID: 30929242
[TBL] [Abstract][Full Text] [Related]
31. Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.
Holmfeldt P; Brännström K; Stenmark S; Gullberg M
Mol Biol Cell; 2006 Jul; 17(7):2921-30. PubMed ID: 16624860
[TBL] [Abstract][Full Text] [Related]
32. Drosophila stathmin is required to maintain tubulin pools.
Fletcher G; Rørth P
Curr Biol; 2007 Jun; 17(12):1067-71. PubMed ID: 17555966
[TBL] [Abstract][Full Text] [Related]
33. Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin.
Manna T; Thrower DA; Honnappa S; Steinmetz MO; Wilson L
J Biol Chem; 2009 Jun; 284(23):15640-9. PubMed ID: 19359244
[TBL] [Abstract][Full Text] [Related]
34. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
35. Thermodynamics of the Op18/stathmin-tubulin interaction.
Honnappa S; Cutting B; Jahnke W; Seelig J; Steinmetz MO
J Biol Chem; 2003 Oct; 278(40):38926-34. PubMed ID: 12860982
[TBL] [Abstract][Full Text] [Related]
36. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.
Stec-Martyna E; Ponassi M; Miele M; Parodi S; Felli L; Rosano C
Curr Cancer Drug Targets; 2012 Jul; 12(6):658-66. PubMed ID: 22385515
[TBL] [Abstract][Full Text] [Related]
37. Insight into the GTPase activity of tubulin from complexes with stathmin-like domains.
Wang C; Cormier A; Gigant B; Knossow M
Biochemistry; 2007 Sep; 46(37):10595-602. PubMed ID: 17711308
[TBL] [Abstract][Full Text] [Related]
38. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
Hari M; Wang Y; Veeraraghavan S; Cabral F
Mol Cancer Ther; 2003 Jul; 2(7):597-605. PubMed ID: 12883031
[TBL] [Abstract][Full Text] [Related]
39. The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration.
Amayed P; Pantaloni D; Carlier MF
J Biol Chem; 2002 Jun; 277(25):22718-24. PubMed ID: 11956188
[TBL] [Abstract][Full Text] [Related]
40. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
